Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (1597)
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
8,340
Price
$1.29
Total Value
$10.75K
Shares Held After
892,101
% of Holdings
0.9%
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
15,000
Price
$96.09
Total Value
$1.44M
Shares Held After
553,209
% of Holdings
2.6%
CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH)
CTT PHARMACEUTICAL HOLDINGS, INC. — Director
Shares
10,900
Price
$0.05
Total Value
$523.20
Shares Held After
9,414,456
% of Holdings
0.1%
VIVOS INC (RDGL)
Weeks Brad Allan — President
Shares
25,550
Price
$0.05
Total Value
$1.23K
Shares Held After
1,547,204
% of Holdings
1.7%
Harvard Apparatus Regenerative Technology, Inc. (HRGN)
He Junli — Director
Shares
6,725
Price
$2.15
Total Value
$14.46K
Shares Held After
1,332,930
% of Holdings
0.5%
CapsoVision, Inc (CV)
Shen Ching Hang — 10% Owner
Shares
878,734
Price
$5.69
Total Value
$5.00M
Shares Held After
2,926,655
% of Holdings
30.0%
908 Devices Inc. (MASS)
Kenneweg John — SVP, Sales&Product Marketing
Shares
1,000
Price
$10.00
Total Value
$10.00K
Shares Held After
57,784
% of Holdings
1.7%
Trevi Therapeutics, Inc. (TRVI)
Heffernan Michael Thomas — Director
Shares
100
Price
$15.88
Total Value
$1.59K
Shares Held After
6,351
% of Holdings
1.6%
Trevi Therapeutics, Inc. (TRVI)
Heffernan Michael Thomas — Director
Shares
20,952
Price
$15.09
Total Value
$316.17K
Shares Held After
6,451
% of Holdings
76.5%
Trevi Therapeutics, Inc. (TRVI)
Heffernan Michael Thomas — Director
Shares
100
Price
$15.88
Total Value
$1.59K
Shares Held After
6,351
% of Holdings
1.6%
Trevi Therapeutics, Inc. (TRVI)
Heffernan Michael Thomas — Director
Shares
18,321
Price
$15.09
Total Value
$276.46K
Shares Held After
6,451
% of Holdings
74.0%
Guardant Health, Inc. (GH)
Chudova Darya — Chief Technology Officer
Shares
7,738
Price
$178.00
Total Value
$1.38M
Shares Held After
70,635
% of Holdings
9.9%
Vera Therapeutics, Inc. (VERA)
Fordyce Marshall — Director
Shares
18,500
Price
$37.00
Total Value
$684.50K
Shares Held After
235,244
% of Holdings
7.3%
CG Oncology, Inc. (CGON)
POST LEONARD E — Director
Shares
1,000
Price
$72.98
Total Value
$72.98K
Shares Held After
0
% of Holdings
100.0%
Travere Therapeutics, Inc. (TVTX)
Inrig Jula — EVP, Head of R&D&CMO
Shares
400
Price
$65.31
Total Value
$26.12K
Shares Held After
100,491
% of Holdings
0.4%
Travere Therapeutics, Inc. (TVTX)
Inrig Jula — EVP, Head of R&D&CMO
Shares
1,600
Price
$63.69
Total Value
$101.90K
Shares Held After
100,891
% of Holdings
1.6%
Travere Therapeutics, Inc. (TVTX)
Inrig Jula — EVP, Head of R&D&CMO
Shares
17,284
Price
$62.62
Total Value
$1.08M
Shares Held After
102,491
% of Holdings
14.4%
Travere Therapeutics, Inc. (TVTX)
Inrig Jula — EVP, Head of R&D&CMO
Shares
25,390
Price
$62.02
Total Value
$1.57M
Shares Held After
119,775
% of Holdings
17.5%
Travere Therapeutics, Inc. (TVTX)
Calvin Sandra — SVP, CHIEF ACCOUNTING OFFICER
Shares
300
Price
$63.66
Total Value
$19.10K
Shares Held After
42,353
% of Holdings
0.7%
Travere Therapeutics, Inc. (TVTX)
Calvin Sandra — SVP, CHIEF ACCOUNTING OFFICER
Shares
800
Price
$62.85
Total Value
$50.28K
Shares Held After
42,653
% of Holdings
1.8%
Travere Therapeutics, Inc. (TVTX)
Calvin Sandra — SVP, CHIEF ACCOUNTING OFFICER
Shares
4,275
Price
$62.13
Total Value
$265.63K
Shares Held After
43,453
% of Holdings
9.0%
Travere Therapeutics, Inc. (TVTX)
Cline Christopher R. — CHIEF FINANCIAL OFFICER
Shares
400
Price
$65.31
Total Value
$26.12K
Shares Held After
87,508
% of Holdings
0.5%
Travere Therapeutics, Inc. (TVTX)
Cline Christopher R. — CHIEF FINANCIAL OFFICER
Shares
1,900
Price
$63.69
Total Value
$121.00K
Shares Held After
87,908
% of Holdings
2.1%
Travere Therapeutics, Inc. (TVTX)
REED ELIZABETH E — Chief Legal Officer and GC
Shares
300
Price
$65.31
Total Value
$19.59K
Shares Held After
105,389
% of Holdings
0.3%
Travere Therapeutics, Inc. (TVTX)
Dube Eric M — Director
Shares
270
Price
$65.31
Total Value
$17.63K
Shares Held After
432,886
% of Holdings
0.1%
Travere Therapeutics, Inc. (TVTX)
Cline Christopher R. — CHIEF FINANCIAL OFFICER
Shares
20,735
Price
$62.61
Total Value
$1.30M
Shares Held After
89,808
% of Holdings
18.8%
Travere Therapeutics, Inc. (TVTX)
Dube Eric M — Director
Shares
3,102
Price
$63.64
Total Value
$197.42K
Shares Held After
433,156
% of Holdings
0.7%
Travere Therapeutics, Inc. (TVTX)
REED ELIZABETH E — Chief Legal Officer and GC
Shares
1,400
Price
$63.69
Total Value
$89.17K
Shares Held After
105,689
% of Holdings
1.3%
Travere Therapeutics, Inc. (TVTX)
Dube Eric M — Director
Shares
28,796
Price
$62.66
Total Value
$1.80M
Shares Held After
436,258
% of Holdings
6.2%
Travere Therapeutics, Inc. (TVTX)
Cline Christopher R. — CHIEF FINANCIAL OFFICER
Shares
27,473
Price
$62.00
Total Value
$1.70M
Shares Held After
110,543
% of Holdings
19.9%
Travere Therapeutics, Inc. (TVTX)
REED ELIZABETH E — Chief Legal Officer and GC
Shares
13,874
Price
$62.63
Total Value
$868.96K
Shares Held After
107,089
% of Holdings
11.5%
Travere Therapeutics, Inc. (TVTX)
Dube Eric M — Director
Shares
63,498
Price
$61.99
Total Value
$3.94M
Shares Held After
465,054
% of Holdings
12.0%
Travere Therapeutics, Inc. (TVTX)
REED ELIZABETH E — Chief Legal Officer and GC
Shares
21,926
Price
$62.03
Total Value
$1.36M
Shares Held After
120,963
% of Holdings
15.3%
Travere Therapeutics, Inc. (TVTX)
ROTE WILLIAM E. — Chief Research Officer
Shares
270
Price
$65.31
Total Value
$17.63K
Shares Held After
98,197
% of Holdings
0.3%
Travere Therapeutics, Inc. (TVTX)
ROTE WILLIAM E. — Chief Research Officer
Shares
3,000
Price
$63.65
Total Value
$190.95K
Shares Held After
98,467
% of Holdings
3.0%
Travere Therapeutics, Inc. (TVTX)
ROTE WILLIAM E. — Chief Research Officer
Shares
29,021
Price
$62.66
Total Value
$1.82M
Shares Held After
101,467
% of Holdings
22.2%
Travere Therapeutics, Inc. (TVTX)
ROTE WILLIAM E. — Chief Research Officer
Shares
63,907
Price
$61.99
Total Value
$3.96M
Shares Held After
130,488
% of Holdings
32.9%
Travere Therapeutics, Inc. (TVTX)
Heerma Peter — EVP, CHIEF COMMERCIAL OFFICER
Shares
1,431
Price
$65.31
Total Value
$93.46K
Shares Held After
117,066
% of Holdings
1.2%
Travere Therapeutics, Inc. (TVTX)
Heerma Peter — EVP, CHIEF COMMERCIAL OFFICER
Shares
1,400
Price
$63.65
Total Value
$89.11K
Shares Held After
118,497
% of Holdings
1.2%
Travere Therapeutics, Inc. (TVTX)
Heerma Peter — EVP, CHIEF COMMERCIAL OFFICER
Shares
27,421
Price
$62.59
Total Value
$1.72M
Shares Held After
119,897
% of Holdings
18.6%
Travere Therapeutics, Inc. (TVTX)
Heerma Peter — EVP, CHIEF COMMERCIAL OFFICER
Shares
71,938
Price
$62.05
Total Value
$4.46M
Shares Held After
147,318
% of Holdings
32.8%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
6,000
Price
$350.07
Total Value
$2.10M
Shares Held After
224,464
% of Holdings
2.6%
Ceribell, Inc. (CBLL)
Blumberg Scott — Chief Financial Officer
Shares
846
Price
$25.00
Total Value
$21.15K
Shares Held After
146,600
% of Holdings
0.6%
Ceribell, Inc. (CBLL)
Chao Xingjuan — Director
Shares
20,846
Price
$25.03
Total Value
$521.78K
Shares Held After
746,345
% of Holdings
2.7%
Roivant Sciences Ltd. (ROIV)
Fitzgerald Meghan — Director
Shares
400
Price
$40.45
Total Value
$16.18K
Shares Held After
36,108
% of Holdings
1.1%
Roivant Sciences Ltd. (ROIV)
Epperly Melissa B, — Director
Shares
600
Price
$40.38
Total Value
$24.23K
Shares Held After
9,900
% of Holdings
5.7%
Roivant Sciences Ltd. (ROIV)
Fitzgerald Meghan — Director
Shares
4,712
Price
$39.68
Total Value
$186.97K
Shares Held After
36,508
% of Holdings
11.4%
Roivant Sciences Ltd. (ROIV)
Epperly Melissa B, — Director
Shares
4,338
Price
$39.65
Total Value
$172.00K
Shares Held After
10,500
% of Holdings
29.2%
Adaptive Biotechnologies Corp (ADPT)
BOBULSKY SUSAN — Chief Commercial Officer, MRD
Shares
1,195
Price
$27.00
Total Value
$32.27K
Shares Held After
395,794
% of Holdings
0.3%
Mineralys Therapeutics, Inc. (MLYS)
Karydas Daphne — Director
Shares
3,000
Price
$28.58
Total Value
$85.74K
Shares Held After
6,200
% of Holdings
32.6%
Showing 151–200 of 1597 transactions (page 4 of 32)